Businesswire News Releases
May 06, 2024 08:08 ET
ALE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ALLETE, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of ALLETE, Inc. (NYSE: ALE) to Canada Pension Plan Investment Board (“CPP”) and Global Infrastructure Partners (“GIP”) for $67.00 per share in cash is fair to ALLETE shareholders....
May 06, 2024 08:03 ET
Ansa Biotechnologies Expands Successful Early Access Program for Complex DNA Synthesis
Ansa Biotechnologies, Inc., the trusted partner for complex DNA synthesis, today announced that it is expanding its early access program for its complex DNA synthesis services. More customers around the world will now be able to take advantage of the company’s innovative enzymatic DNA synthesis technology to accelerate innovation in healthcare, ...
May 06, 2024 08:00 ET
Al Capone’s Iconic Colt .45 Pistol “The Sweetheart”
On May 18th at 3pm ET, online, via phone, and in person, Richmond Auctions will present to the world “The Sweetheart,” Al Capone’s legendary personal protection Colt 1911 firearm that he often described as his favorite gun and credited for saving his life on several occasions. Highly sought-after firearms from famous historical figures have consistently sold for millions in recent auctions, such as Ulysses Grant’s pistols that sold for over $5 million, and Pat Garrett’s Colt revolver that sold for over $6 million. With a similar estimate to the Pat Garrett Colt revolver, Capone’s “Sweetheart” ...
May 06, 2024 08:00 ET
Alight Names Two New Independent Directors, Dave Guilmette and Coretha Rushing, to its Board of Directors
Alight, Inc. (NYSE: ALIT) (“Alight” or the “Company”), a leading cloud-based human capital and technology services provider, today announced the appointment of Dave Guilmette and Coretha Rushing as independent directors to its Board of Directors (the “Board”), effective immediately. These appointments have been made in connection with a cooperation agreement (the “Agreement”) entered into between Alight and Starboard Value LP (together with certain of its affiliates, “Starboard”), an investment firm which owns approximately 7.2% of the Company’s outstanding common stock....
May 06, 2024 08:00 ET
Americans are Concerned About Ticks and Tick-borne Diseases: How to Stay Protected
It is peak tick season, and with warmer temperatures on the upswing, so are tick populations across the U.S. Ticks are dangerous pests that can transmit disease-causing pathogens at alarming rates. It’s no surprise that 1 in 4 Americans (25%) are concerned about tick bites and tick-borne diseases, according to a recent NPMA survey conducted by The Harri...
May 06, 2024 08:00 ET
Chrysalis BioTherapeutics Selected to Present at Respiratory Innovation Summit
Chrysalis BioTherapeutics today announced it was selected to participate in the 2024 Respiratory Innovation Summit (RIS) at the American Thoracic Society Meeting in San Diego....
May 06, 2024 08:00 ET
Clean Air Partners Urges Region to Fight Hidden Backyard Pollution Hazards
With spring upon us, and ozone season just around the corner, Clean Air Partners (CAP) invites Baltimore-Washington residents to replace their gas powered lawn tools (lawn mowers, leaf blowers and grass trimmers) with more eco-friendly electric versions. Kicking off the campaign with
May 06, 2024 08:00 ET
Cloud Security Alliance Releases Three Papers Offering Guidance for Successful Artificial Intelligence (AI) Implementation
RSA Conference -- The Cloud Security Alliance (CSA), the world’s leading organization dedicated to defining standards, certifications, and best practices to help ensure a secure cloud computing environment, today issued
May 06, 2024 08:00 ET
Drop Woke Products, Swap to Better, Family-First Alternatives
PSQ Holdings, Inc. (NYSE: PSQH) (“PublicSquare,” or the “Company”), a leading marketplace of patriotic businesses and consumers, today announced their brand new initiative, “30 Products to Swap.” From household goods to clothing and pantry essentials, PublicSquare will offer consumers a promotional opportunity to stop purchasing from woke corporations and switch to values-aligned American brands completely risk-free....
May 06, 2024 08:00 ET
Dynatrace to Present at Upcoming Investor Conferences
Dynatrace (NYSE: DT), the leader in unified observability and security, today announced that its executives will present at three upcoming investor conferences, as follows:...
May 06, 2024 08:00 ET
Engine Capital Calls on Dye & Durham’s Board Not to Issue Shares Ahead of the Special Meeting
Engine Capital LP, which owns approximately 6.6% of Dye & Durham Limited’s (TSX: DND) outstanding shares, today issued the following open letter to Dye & Durham’s Board of Directors....
May 06, 2024 08:00 ET
Fifth Third Gives Families a College Savings Head Start
Fifth Third recognizes the burden that the cost of education can put on parents – whether it is a college program, vocational or trade school – and has once again provided a savings boost for future education. 115 babies in Northeast Ohio and Tampa Bay who were born on “Fifth Third Day” (5/3 on the calendar) received a gift of $1,053 to be put toward a
May 06, 2024 08:00 ET
Komodo Health & Partners Present 33 Real-World Evidence Research Studies at ISPOR 2024
Komodo Health today announced the publication of 33 new health economics and outcomes research (HEOR) studies using its Healthcare Map and AI-powered technology platform. The studies, to be featured at the 2024 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Global Conference, shed light on important disease trends spanning women’s health, oncology, mental health, hypertension, neurology, and more....
May 06, 2024 08:00 ET
Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System
Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies currently celebrating its 35th anniversary, announced FDA clearance of Stork™, a baby monitoring system that provides alarms to parents or other caregivers, for use with healthy babies 0-18 months of age, without the need for a prescription....
May 06, 2024 08:00 ET
Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of TabloCartTM with prefiltration, an innovative optional accessory for th...
May 06, 2024 08:00 ET
Perfect Corp. Unveils Unique ‘Beautiful AI’ Brand Solutions for Beauty, Skincare, and Fashion at Viva Technology 2024
Perfect Corp., the leading AI and AR beauty and fashion technology provider and developer of Beautiful AI solutions – a complete range of AI-powered innovations that transform brands and make the user’s world beautiful - proudly announces brand new a...
May 06, 2024 08:00 ET
Phonak Announces FDA Cleared Self-Replacement Option for Lyric™ Hearing Device
Phonak, a leading global provider of life-changing hearing solutions, today announces an FDA cleared self-replacement option for Phonak Lyric, the world’s only 100% invisible hearing aid that provides 24/7 hassle-free hearing with proven tinnitus relief. With the new clearance, certified Lyric providers in the U.S. can now offer exp...
May 06, 2024 08:00 ET
Redfin Reports Low-Income Americans Have Lost the Homebuying Progress They Made During the Pandemic
(NASDAQ: RDFN) — Roughly one in five (20.6%) new mortgages issued last year went to low-income Americans, bringing that group’s piece of the homebuying pie back down to where it was in 2018. That is according to a new report from Redfin (
May 06, 2024 08:00 ET
Results from Pivotal Clinical Study Demonstrate Potential of Nucleix’s Bladder EpiCheck® to Improve Disease Recurrence Detection in Non-Muscle Invasive Bladder Cancer (NMIBC) Surveillance
Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, announced that the results from the company's North American pivotal clinical study evaluating the performance of Bladder EpiCheck® as a non-invasive and objective novel methylation-based PCR urine test for the surveillance of non-muscle invasive bladder...
May 06, 2024 08:00 ET
Sampling Human Ships its First Kits for Cellular Analysis to Early Access Customers and Releases an App Note with BMG LABTECH
Sampling Human, Inc., a techbio company developing single cell technologies, announces the delivery of its Apoptosis (Anti-PS) Biocytometry Kits to Early Access customers. In addition, Sampling Human has partnered with
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.